Generics of Vyvanse, Takeda's ADHD drug, get FDA green light

Takeda Pharmaceutical Company Limited just lost exclusivity on its ADHD drug.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 28, 2023 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news